Evidence map›Paper›PMID 26102079›Full record

ArticlePloS one2015

Prevalence, Awareness, Treatment and Influence of Socioeconomic Variables on Control of High Blood Pressure: Results of the ELSA-Brasil Study.

Dóra Chor, Antonio Luiz Pinho Ribeiro, Marilia Sá Carvalho, Bruce Bartholow Duncan, Paulo Andrade Lotufo, Aline Araújo Nobre, Estela Mota Lima Leão de Aquino, Maria Inês Schmidt, Rosane Härter Griep, Maria Del Carmen Bisi Molina and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 3 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 3 syntheses or guidelines pooled it, 239 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Factors associated with non-treatment of hypertension and gender differences at baseline in the ELSA-Brasil cohort.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Dóra ChorDepartment of Epidemiology, National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Antonio Luiz Pinho RibeiroDepartment of Internal Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Marilia Sá CarvalhoScientific Computing Program, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Bruce Bartholow DuncanPostgraduate Studies Program in Epidemiology, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Paulo Andrade LotufoSchool of Medicine, University of Sao Paulo, São Paulo, SP, Brazil.
Aline Araújo NobreScientific Computing Program, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Estela Mota Lima Leão de AquinoInstitute of Collective Health, Federal University of Bahia, Salvador, BA, Brazil.
Maria Inês SchmidtPostgraduate Studies Program in Epidemiology, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Rosane Härter GriepLaboratory of Health and Environment Education, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Maria Del Carmen Bisi MolinaPost Graduate Program of Collective Health, Federal University of Espírito Santo, Vitória, ES, Brazil.
Sandhi Maria BarretoFaculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Valéria Maria de Azeredo PassosFaculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
Isabela Judith Martins BenseñorSchool of Medicine, University of Sao Paulo, São Paulo, SP, Brazil.
Sheila Maria Alvim MatosInstitute of Collective Health, Federal University of Bahia, Salvador, BA, Brazil.
José Geraldo MillDepartment of Physiological Sciences, Federal University of Espirito Santo, Vitória, ES, Brazil.
Fundação Oswaldo Cruz · BRUniversidade Federal de Minas Gerais · BRUniversidade de São Paulo · BRUniversidade Federal da Bahia · BRUniversidade Federal do Espírito Santo · BRUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High blood pressure (HBP) is the leading risk factor for years of life lost in Brazil. Factors associated with HBP awareness, treatment and control need to be understood better. Our aim is to estimate prevalence, awareness, and types of anti-hypertensive treatment and to investigate the association of HBP control with social position. Data of 15,103 (54% female) civil servants in six Brazilian state capitals collected at the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) baseline (2008-2010) were used to estimate prevalence and cross-sectional association of HBP control with education, per capita family income and self-reported race, using multiple logistic regression. Blood pressure was measured by the oscillometric method. 35.8% were classified as presenting HBP; 76.8% of these used anti-hypertensive medication. Women were more aware than men (84.8% v. 75.8%) and more often using medication (83.1% v. 70.7%). Adjusted HBP prevalence was, in ascending order, Whites (30.3%), Browns (38.2%) and Blacks (49.3%). The therapeutic schemes most used were angiotensin-converting enzyme inhibitors, in isolation (12.4%) or combined with diuretics (13.3%). Among those in drug treatment, controlled blood pressure was more likely in the (postgraduate) higher education group than among participants with less than secondary school education (PR = 1.21; 95% CI: 1.14-1.28), and among Asian (PR = 1.21; 95% CI: 1.12-1.32) and 'Whites (PR = 1.19; 95% CI: 1.12-1.26) compared to Blacks. Socioeconomic and racial inequality-as measured by different indicators-are strongly associated with HBP control, beyond the expected influence of health services access.

Indexed as

AwarenessSocioeconomic FactorsAdultAgedAntihypertensive AgentsBrazilFemaleHumansHypertensionLongitudinal StudiesMaleMiddle AgedPrevalenceAntihypertensive Agents

Identifiers

PMID26102079
PMCPMC4478044
OpenAlexW784773356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.